 RespireRx Pharmaceuticals OTCQB:RSPI Inc announced that its dronabinol obstructive sleep apnea OSA program has been featured in a free e-book published in the June 13, 2022, edition of Sleep Review magazine. The e-book, entitled How Close Are We to Drug Therapy for Obstructive Sleep Apnea? 